P
WST icon

Pitcairn’s West Pharmaceutical WST Stock Holding History

Pitcairn’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-6,601
Closed -$1.73M – 602
2025
Q3 		$1.73M Sell
6,601
-2,036
-24% -$495K 0.14% 133
2025
Q2 		$1.89M Sell
8,637
-3,991
-32% -$853K 0.12% 153
2025
Q1 		$2.83M Buy
12,628
+5,126
+68% +$1.41M 0.17% 113
2024
Q4 		$2.46M Buy
7,502
+2,263
+43% +$712K 0.15% 127
2024
Q3 		$1.57M Buy
5,239
+4,328
+475% +$1.33M 0.09% 201
2024
Q2 		$300K Buy
911
+36
+4% +$12.7K 0.02% 587
2024
Q1 		$346K Buy
875
+29
+3% +$10.7K 0.02% 539
2023
Q4 		$298K Sell
846
-19
-2% -$6.72K 0.02% 540
2023
Q3 		$325K Sell
865
-21
-2% -$8.12K 0.03% 478
2023
Q2 		$339K Sell
886
-5
-0.6% -$1.79K 0.03% 480
2023
Q1 		$309K Sell
891
-22
-2% -$6.43K 0.03% 485
2022
Q4 		$215K Buy
913
+57
+7% +$13.5K 0.02% 551
2022
Q3 		$211K Sell
856
-44
-5% -$13.4K 0.02% 541
2022
Q2 		$272K Sell
900
-9
-1% -$2.93K 0.03% 464
2022
Q1 		$373K Sell
909
-12
-1% -$4.7K 0.03% 447
2021
Q4 		$432K Sell
921
-197
-18% -$84.8K 0.03% 410
2021
Q3 		$475K Sell
1,118
-44
-4% -$18.5K 0.03% 363
2021
Q2 		$417K Buy
1,162
+109
+10% +$36K 0.03% 404
2021
Q1 		$297K Buy
1,053
+13
+1% +$3.72K 0.02% 493
2020
Q4 		$294K Buy
1,040
+177
+21% +$49.7K 0.02% 448
2020
Q3 		$237K Sell
863
-38
-4% -$10.1K 0.02% 442
2020
Q2 		$204K Buy
+901
New +$177K 0.02% 466

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Pitcairn's WST Position: Q4 2025 in Review

Pitcairn sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 6,601 shares — an estimated $1.73M sold.

Pitcairn first reported a position in WST in Q2 2020 and held it in 22 quarters. The position peaked at $2.83M in Q1 2025. 802 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Pitcairn reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Pitcairn sold 6,601 West Pharmaceutical shares in Q4 2025, an estimated $1.73M.
  • Pitcairn first reported a position in West Pharmaceutical in Q2 2020 and held it in 22 quarters.
  • Pitcairn's West Pharmaceutical position peaked at $2.83M in Q1 2025.
  • 802 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.